Stock DNA
Pharmaceuticals & Biotechnology
CNY 7,425 Million (Mid Cap)
7.00
NA
7.89%
-1.00
36.16%
2.67
Revenue and Profits:
Net Sales:
541 Million
(Quarterly Results - Jun 2025)
Net Profit:
293 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
30.17%
0%
30.17%
6 Months
25.56%
0%
25.56%
1 Year
2.49%
0%
2.49%
2 Years
-10.05%
0%
-10.05%
3 Years
-26.81%
0%
-26.81%
4 Years
24.57%
0%
24.57%
5 Years
-2.69%
0%
-2.69%
Shandong Wit Dyne Health Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
3.25%
EBIT Growth (5y)
17.78%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-1.01
Sales to Capital Employed (avg)
0.78
Tax Ratio
14.60%
Dividend Payout Ratio
113.62%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
291.53%
ROE (avg)
33.88%
Valuation key factors
Factor
Value
P/E Ratio
7
Industry P/E
Price to Book Value
2.67
EV to EBIT
4.17
EV to EBITDA
3.90
EV to Capital Employed
405.22
EV to Sales
2.21
PEG Ratio
NA
Dividend Yield
7.89%
ROCE (Latest)
9728.40%
ROE (Latest)
36.16%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
540.90
607.20
-10.92%
Operating Profit (PBDIT) excl Other Income
345.70
411.20
-15.93%
Interest
0.00
0.00
Exceptional Items
0.70
4.30
-83.72%
Consolidate Net Profit
293.30
345.80
-15.18%
Operating Profit Margin (Excl OI)
607.20%
648.70%
-4.15%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -10.92% vs -18.38% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is -15.18% vs 10.34% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
2,098.10
2,444.20
-14.16%
Operating Profit (PBDIT) excl Other Income
1,183.00
1,335.80
-11.44%
Interest
0.50
0.60
-16.67%
Exceptional Items
10.00
14.00
-28.57%
Consolidate Net Profit
1,006.00
1,127.10
-10.74%
Operating Profit Margin (Excl OI)
527.00%
515.00%
1.20%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -14.16% vs 6.22% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -10.74% vs 12.95% in Dec 2023
About Shandong Wit Dyne Health Co., Ltd. 
Shandong Wit Dyne Health Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






